植皮のアメリカ市場:企業概要・規模・シェア・成長・動向・予測(~2025年)

【英語タイトル】U.S. Skin Graft Market Analysis : Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Data Bridge Market Researchが出版した調査資料(DBMR810293)・商品コード:DBMR810293
・発行会社(調査会社):Data Bridge Market Research
・発行日:2018年2月
・ページ数:84
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:アメリカ
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Web Access)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Corporate UserUSD3,200 ⇒換算¥361,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Data Bridgeが出版した本調査レポートでは、植皮のアメリカ市場について調査・分析し、植皮のアメリカ市場動向、市場予測、セグメント別分析、植皮市場規模、関連企業分析などを含め以下の構成でお届けいたします。
【レポートの概要】

U.S. skin graft market is expected to reach USD 522.52 million by 2025 from USD 293.00 million in 2017, at a CAGR of 7.6% in the forecast period 2018 to 2025.The major factors driving the growth of this market are increasing number of burns injuries, pressure ulcers and skin infections, developments in skin grafting techniques and technological advances in dermatomes are boosting the growth of the U.S. skin graft market.
The key market players for U.S. skin graft market are listed below:

• Integra Lifesciences Corporation
• Organogenesis, Inc.
• Zimmer Biomet, Inc.
• B. Braun Melsungen AG
• Nouvag AG
• DE Soutter Medical Limited
• Surtex Instruments Limited
• Exsurco Medical, Inc.

The market is further segmented into:
• Type
• Graft Thickness
• Application
• Equipment Type
• End-user

The U.S. skin graft market is segmented on the basis of type, graft thickness, application, equipment type, and end-user. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.
The U.S. skin graft market is segmented based on type into autologous, allogeneic, xenogeneic, prosthetic and isogeneic. In 2018, autologous is expected to dominate the U.S. skin graft market with 38.5% market share and is expected to reach USD 207.25 million by 2025, growing at the highest CAGR of 8.1% in the forecast period of 2018 to 2025.
The U.S. skin graft market is segmented based on graft thickness into split-thickness, full-thickness, and composite graft. In 2018, split-thickness is expected to dominate the U.S. skin graft market with 47.9% market share and is expected to reach USD 254.38 million by 2025, growing at the highest CAGR of 7.8% in the forecast period 2018 to 2025.
The U.S. skin graft market is segmented based on application into burns, extensive wound, skin cancer, and extensive skin loss due to infection. In 2018, burns is expected to dominate the U.S. skin graft market with 46.7% market share and is expected to reach USD 251.53 million by 2025, growing at the highest CAGR of 8.1% in the forecast period 2018 to 2025.
The U.S. skin graft market is segmented based on equipment type into dermatome, general surgical instruments, consumables, and others. In 2018, dermatome is expected to dominate the U.S. Skin graft market with 43.7% market share and is expected to reach USD 235.29 million by 2025, growing at the highest CAGR of 8.1% in the forecast period 2018 to 2025.
Dermatome is further sub-segmented into electrical dermatomes, air-powdered dermatomes, knife dermatomes, and drum dermatomes. In 2018, electrical dermatomes is expected to dominate the U.S. Skin graft market with 47.6% market share and is expected to reach USD 115.88 million by 2025, growing at the highest CAGR of 8.6% in the forecast period 2018 to 2025.
Knife dermatome is further sub-segmented into Watson Knife, Cobbett Knife, and Blair/Brown Knife. In 2018, Watson Knife is expected to dominate the U.S. skin graft market with 53.9% market share and is expected to reach USD 63.51 million by 2025, growing at the highest CAGR of 8.8% in the forecast period 2018 to 2025.
Drum dermatome is further sub-segmented into Padgett Dermatomes, and Reese Dermatomes. In 2018, Padgett Dermatomes is expected to dominate the U.S. skin grafts market with 61.5% market share and is expected to reach USD 317.01 million by 2025, with a CAGR of 7.4% in the forecast period 2018 to 2025. However, Reese Dermatomes is expected to grow at the highest CAGR of 7.9% in the forecast period, to reach USD 205.51 million by 2025 from USD 112.51 million in 2017 in the forecast period 2018 to 2025.
The U.S. skin graft market is segmented on the basis of end users into ambulatory surgical centers, hospitals, and dermatology clinics. In 2018, ambulatory surgical centers is expected to dominate the U.S. skin graft market with 53.2% market share and is expected to reach USD 282.82 million by 2025, growing at the highest CAGR of 7.9% in the forecast period 2018 to 2025.
Covered in this report
The report covers the present scenario and the growth prospects of the U.S. skin graft market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table Of Contents

1. Introduction 11
1.1. Objectives Of The Study 11
1.2. Market Definition 11
1.3. Overview Of U.S. Skin Graft Market 11
1.4. Currency And Pricing 12
1.5. Limitation 12
1.6. Markets Covered 13
2. Market Segmentation 14
2.1. Markets Covered 14
2.2. Years Considered For The Study 15
2.3. Currency And Pricing 15
2.4. Research Methodology 16
2.5. Primary Interviews With Key Opinion Leaders 19
2.6. Secondary Sources 20
2.7. Assumptions 20
3. Market Overview 21
3.1. Drivers 23
3.1.1. Increasing Number Of Burns Injuries, Pressure Ulcers, And Skin Infections 23
3.1.2. Technological Advancements And Developments In Skin Grafting Techniques 24
3.1.3. Favorable Reimbursement Policies For Skin Grafting Procedure 25
3.2. Restraints 26
3.2.1. Side Effects Related To The Skin Graft Procedure 26
3.3. Opportunities 27
3.3.1. Increasing Medical Tourisms 27
3.4. Challenges 28
3.4.1. Competition Among Major Players In The U.S. 28
4. Executive Summary 29
5. Premium Insights 31
6. U.S. Skin Graft Market, By Type 33
6.1. Overview 34
6.2. Autologous 35
6.3. Isogeneic 36
6.4. Allogeneic 36
6.5. Xenogeneic 36
6.6. Prosthetic 37
7. U.S. Skin Graft Market, By Graft Thickness 38
7.1. Overview 39
7.2. Split-Thickness 41
7.3. Full-Thickness 41
7.4. Composite Graft 41
8. U.S. Skin Graft Market, By Application 42
8.1. Overview 43
8.2. Extensive Wound 45
8.3. Extensive Skin Loss Due To Infection 45
8.4. Skin Cancer 46
8.5. Burns 46
9. U.S. Skin Graft Market, By Equipment Type 47
9.1. Overview 48
9.2. Dermatome 49
9.2.1. Knife Dermatomes 50
9.2.1.1. Blair/Brown Knife 51
9.2.1.2. Watson Knife 51
9.2.1.3. Cobbett Knife 52
9.2.2. Drum Dermatomes 52
9.2.2.1. Padgett Dermatomes 53
9.2.2.2. Reese Dermatomes 53
9.2.3. Electrical Dermatomes 53
9.2.4. Air-Powdered Dermatomes 54
9.3. General Surgical Instruments 55
9.4. Consumables 55
9.5. Others 55
10. U.S. Skin Graft Market, By End User 56
10.1. Overview 57
10.2. Hospitals 59
10.3. Dermatology Clinics 59
10.4. Ambulatory Surgical Centers 59
11. U.S. Skin Graft Market, Company Landscape 60
11.1. Company Share Analysis: North America 60
12. Company Profiles 61
12.1. Organogenesis Inc. 61
12.1.1. Company Overview 61
12.1.2. Organogenesis Inc.: Company Snapshot 61
12.1.3. Product Portfolio 62
12.1.4. Recent Developments 62
12.2. Integra Lifesciences Corporation 63
12.2.1. Company Overview 63
12.2.2. Integra Lifesciences Corporation: Revenue Analysis 63
12.2.3. Product Portfolio 64
12.2.4. Recent Developments 65
12.3. Zimmer Biomet 66
12.3.1. Company Overview 66
12.3.2. Zimmer Biomet: Revenue Analysis 66
12.3.3. Product Portfolio 67
12.3.4. Recent Developments 67
12.4. B. Braun Melsungen Ag 68
12.4.1. Company Overview 68
12.4.2. B. Braun Melsungen Ag: Revenue Analysis 68
12.4.3. Product Portfolio 69
12.4.4. Recent Developments 69
12.5. Avita Medical 70
12.5.1. Company Overview 70
12.5.2. Avita Medical :Revenue Analysis 70
12.5.3. Product Portfolio 71
12.5.4. Recent Developments 71
12.6. De Soutter Medical 72
12.6.1. Company Overview 72
12.6.2. De Soutter Medical: Company Snapshot 72
12.6.3. Product Portfolio 73
12.6.4. Recent Developments 73
12.7. Exsurco Medical, Inc. 74
12.7.1. Company Overview 74
12.7.2. Exsurco Medical, Inc.:Company Snapshot 74
12.7.3. Product Portfolio 75
12.7.4. Recent Developments 75
12.8. Mallinckrodt 76
12.8.1. Company Overview 76
12.8.2. Mallinckrodt: Revenue Analysis 76
12.8.3. Product Pipeline 77
12.8.4. Recent Developments 77
12.9. Nouvag 78
12.9.1. Company Overview 78
12.9.2. Nouvag: Company Snapshot 78
12.9.3. Product Portfolio 79
12.9.4. Recent Developments 79
12.10. Surtex Instruments Limited 80
12.10.1. Company Overview 80
12.10.2. Surtex Instruments Limited: Company Snapshot 80
12.10.3. Product Portfolio 81
12.10.4. Recent Developments 81
12.11. Tissue Regenix 82
12.11.1. Company Overview 82
12.11.2. Tissue Regenix: Revenue Analysis 82
12.11.3. Product Portfolio 83
12.11.4. Recent Developments 83
13. Related Reports 84

Figures List
Figure 1 U.S. Skin Graft Market : Segmentation 14
Figure 2 U.S. Skin Graft Market: Data Triangulation 16
Figure 3 U.S. Skin Graft Market: Research Snapshot 17
Figure 4 U.S. Skin Graft Market : Bottom Up Approach 18
Figure 5 U.S. Skin Graft Market : Top Down Approach 18
Figure 6 U.S. Skin Graft Market: Interview Demographics 19
Figure 7 Drivers, Restraints, Opportunities, And Challenges In
U.S. Skin Graft Market 22
Figure 8 U.S. Skin Graftmarket: Segmentation 30
Figure 9 Increasing Number Of Burns Injuries, Pressure Ulcers, Skin Infections, And Developments In Skin Grafting Techniques Are Expected To Drive The Market For U.S. Skin Graft In The Forecast Period 2018 To 2025 31
Figure 10 Autologous Segment Is Expected To Account For The Largest Share Of The U.S. Skin Graft Market In 2018 & 2025 32
Figure 11 U.S. Skin Graft Market: By Type, 2017 34
Figure 12 U.S. Skin Graft Market: By Graft Thickness, 2017 39
Figure 13 U.S. Skin Graft Market: By Application, 2017 43
Figure 14 U.S. Skin Graft Market: By Equipment Type, 2017 48
Figure 15 U.S. Skin Graft Market: By End User, 2017 57
Figure 16 U.S. Skin Graft Market: Company Share 2017 (%) 60


【レポートのキーワード】

植皮

★調査レポート[植皮のアメリカ市場:企業概要・規模・シェア・成長・動向・予測(~2025年)] (コード:DBMR810293)販売に関する免責事項を必ずご確認ください。
★調査レポート[植皮のアメリカ市場:企業概要・規模・シェア・成長・動向・予測(~2025年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆